RETRACTED: Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma-Reference-Cited by-同舟云学术

RETRACTED: Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma

Published:2019-01 Issue: Volume:109 Page:798-805
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Qi Defeng,Wang Mingming,Yu Fenghua

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference36 articles.

1. Current therapy and recent advances in the management of retinoblastoma;Meel;Indian J. Med. Paediatr. Oncol.,2012

2. BANCR: a novel oncogenic long non-coding RNA in human cancers;Zou;Oncotarget,2017

3. A tale of absent crystalline Lens in an eye with retinoblastoma;Bansal;Ocul. Oncol. Pathol.,2018

4. Retinoblastoma;Rodriguez-Galindo;Pediatr. Clin. N. Am.,2015

5. Disparities in retinoblastoma presentation, treatment, and outcomes in developed and less-developed countries;Singh;Semin. Ophthalmol.,2016

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From diagnosis to therapy: The transformative role of lncRNAs in eye cancer management;Pathology - Research and Practice;2024-02

2. ncR2Met (lncR2metasta v2.0): An updated database for experimentally supported ncRNAs during cancer metastatic events;Genomics;2023-03

3. Structure and Function of the H19 Long Non-coding RNA in Cancer;Interdisciplinary Cancer Research;2023

4. Long non-coding RNAs involved in retinoblastoma;Journal of Cancer Research and Clinical Oncology;2022-10-28

5. Retraction notice to “Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma” [Biomed. Pharmacother. 109 (2019) 798–805];Biomedicine & Pharmacotherapy;2022-06